Quick Heal Technologies Ltd
Quick Heal Technologies Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
1 of 3 strong
The short version
Quick Heal anticipates the enterprise vertical to be the primary growth driver over the next 2-3 years, targeting it to comprise 80-90% of revenue. Quick Heal is undergoing a transition from a B2C antivirus to a holistic cybersecurity company, focusing on enterprise business.
From Quick Heal Technologies Ltd's Q4 FY26 earnings-call transcript · updated 4 Sept 2026.
Revenue & Sales Performance
- Quick Heal anticipates the enterprise vertical to be the primary growth driver over the next 2-3 years, targeting it to comprise 80-90% of revenue.
- Enterprise business showed consistent growth, especially in government and BFSI segments, supported by increased deferred revenue and a strong order book.
- Strategic investments are being made to expand in South East Asia, Middle East, Africa, and Latin America.
- Cloud adoption in security solutions is increasing rapidly, now contributing 40% to EPP and EDR deployments, up from 20% two years ago.
- New offerings like Digital Risk Protection Services (DRPS), Ransomware Recovery as a Service (RRAS), and data privacy solutions are expected to gain traction with increased regulatory compliance needs.
2 more points from Quick Heal Technologies Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Quick Heal Technologies Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company continues to invest significantly in R&D, fully expensing these investments in the year incurred.
- Strategic investments have been made in expanding market presence in South East Asia, Middle East Africa, and Latin America.
- Investment focus on AI-driven technologies, threat intelligence, data privacy, and scalable global capabilities to stay ahead in the cybersecurity industry transformation.
- There is a clear emphasis on Make in India initiatives targeting government business and international penetration.
2 more points from Quick Heal Technologies Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in IT - Software
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Quick Heal Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Current order book stands at Rs. 55 crores for FY’26, up from Rs. 6 crores in FY’25.
- Deferred revenue increased to Rs. 34 crores from Rs. 14 crores in the previous year.
- Successfully executed a cyber literacy order received in February 2025.
- Secured an additional order worth Rs. 64 crores related to the implementation of integrated cybersecurity solutions.
2 more points from Quick Heal Technologies Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Quick Heal Technologies Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹49 Cr, net loss ₹20 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Quick Heal Technologies Ltd's management said in earlier quarters
- Q4 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY24 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
Others in IT - Software this season
- Systango Tech (Q4 FY26)
For FY26 (full year), Revenue from Operations is reported at INR 904 million, up 34.72% year-on-year from INR 671 million in FY25 (Page 26). Key investor presen
- Cybertech Sys. (Q4 FY26)
Q4FY26 Operating Revenue: ₹623.3 million, up 1.4% YoY (Q4FY25 Operating Revenue: ₹614.9 million) . Key investor presentation takeaways from Cybertech Systems &
- ASM Technologies (Q4 FY26)
Revenue from Operations for Q4 FY26: ₹135.1 Cr, up 18.0% YoY from ₹114.5 Cr in Q4 FY25 (Page 8). Key concall takeaways from ASM Technologies Ltd's Q4 FY26…
- 3i Infotech Ltd (Q4 FY26)
77 crore. Key concall takeaways from 3i Infotech's Q4 FY26 earnings call — and how it ranks against sector peers.
Arthneeti Pro · Annual
Quick Heal Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Quick Heal Technologies Ltd Q4 FY26 results?
Quick Heal anticipates the enterprise vertical to be the primary growth driver over the next 2-3 years, targeting it to comprise 80-90% of revenue. Quick Heal is undergoing a transition from a B2C antivirus to a holistic cybersecurity company, focusing on enterprise business.
What is Quick Heal Technologies Ltd share price analysis?
Quick Heal Technologies Ltd currently shows a below-average growth signal. The stock trades at a P/E of N/A with a market cap of ₹753 Cr. Investors should review the full earnings analysis for detailed insights.
Is Quick Heal Technologies Ltd planning capital expenditure?
The company continues to invest significantly in R&D, fully expensing these investments in the year incurred.
Keep Quick Heal Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.